A conversation with Dr. Petra Schulz Discussing MetrioPharm’s Phase II Clinical Study in COVID-19
MetrioPharm is currently preparing a clinical trial of its lead compound MP1032 in COVID-19. How do you conduct study preparations under pandemic conditions?
The landscape has changed...
